These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3893084)

  • 1. Therapeutic inequivalence of pharmaceutical alternates.
    Levy RA
    Am Pharm; 1985 Apr; NS25(4):28-39. PubMed ID: 3893084
    [No Abstract]   [Full Text] [Related]  

  • 2. [The consequence of the preparation factors for the effect of the drug].
    Johnsgård M; Pedersen AO
    Tidsskr Nor Laegeforen; 1973 Apr; 93(10):698-703. PubMed ID: 4755086
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioavailability and bioequivalence of topical glucocorticoids.
    Wiedersberg S; Leopold CS; Guy RH
    Eur J Pharm Biopharm; 2008 Mar; 68(3):453-66. PubMed ID: 17826047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug biodisponibility and generic equivalence (author's transl)].
    Jaminet F
    J Pharm Belg; 1977; 32(4):325-46. PubMed ID: 599404
    [No Abstract]   [Full Text] [Related]  

  • 6. Generic inequivalence--clinical observations.
    Prescott LF; Nimmo J
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():288-303. PubMed ID: 5317801
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of formulation factors on the availability of drugs from topical preparations.
    Asche H; Botta L; Rettig H; Weirich EG
    Pharm Acta Helv; 1985; 60(8):232-7. PubMed ID: 4070318
    [No Abstract]   [Full Text] [Related]  

  • 9. [Absorption of the drug-contents of enteric-coated tablets].
    Tikkanen R
    Nord Med; 1967 Nov; 78(47):1564-7. PubMed ID: 6075282
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral controlled release preparations.
    García CR; Siqueiros A; Benet LZ
    Pharm Acta Helv; 1978; 53(3-4):99-109. PubMed ID: 360228
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tablets in stool? A common problem!].
    Schuerch LV; Nyfeler J; Holder G; Surber C; Haefeli WE
    Schweiz Med Wochenschr; 1999 May; 129(17):670-3. PubMed ID: 10407938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striving for standards in bioequivalence assessment: a review.
    Schulz HU; Steinijans VW
    Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S1-6. PubMed ID: 1601528
    [No Abstract]   [Full Text] [Related]  

  • 13. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
    Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
    Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swallowing difficulties protocol: medication administration.
    Wright D
    Nurs Stand; 2002 Dec 18-31; 17(14-15):43-5. PubMed ID: 12567798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of formulation of enterosoluable preparations on the physiologic availability of the active principle. 1: Effect on the rate of liberation of acetylsalicylic acid from enteric tablets on absorption characteristics in vivo].
    Delporte JP; Jaminet F
    J Pharm Belg; 1975; 30(2):99-113. PubMed ID: 1206458
    [No Abstract]   [Full Text] [Related]  

  • 16. Bioavailability of two clodronate formulations.
    Lapham G; Aranko K; Hanhijärvi H; Humphreys DM
    Br J Hosp Med; 1996 Sep 4-17; 56(5):231-3. PubMed ID: 8879704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of ethylcellulose as an excipient for delayed action preparations].
    Gumma A; Dermanci MA; Bel F
    Pharm Acta Helv; 1972 Oct; 47(10):577-87. PubMed ID: 4642456
    [No Abstract]   [Full Text] [Related]  

  • 18. Valproic acid delayed release (Stavzor).
    Med Lett Drugs Ther; 2009 Apr; 51(1309):27-8. PubMed ID: 19343008
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug absorption and problems of biological availability of tablets and capsules].
    Cascioli D; Petrangeli B
    Boll Chim Farm; 1978 Sep; 117(9):502-21 contd. PubMed ID: 752358
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral troches. A study of potential pharmaceutical vehicles.
    Kutscher AH; Zegarelli EV; Kanig JL; Montana R; Amundsen A
    J Oral Med; 1967 Jul; 22(3):100-2. PubMed ID: 5235026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.